We will be exhibiting at 2016 BIO, San Francisco
30, May 2016
Holy Stone Healthcare Co., Ltd., together with representatives of Holy Stone Biotech Co., Ltd & MDT Int’l S.A., will be exhibiting at 2016 BIO International Convention in USA. The event will be held from June 7th – 9th at Moscone Center, San Francisco.
During the exhibition, two major developing products using our Hyaluronan Drug Delivery (HDD) Technique will be introduced: IBD98-M & CA102N. IBD98-M is a combination drug to treat mild to moderate Ulcerative Colitis, and CA102N is an anti-cancer drug-conjugate for targeted delivery to malignant cells. Four medical devices currently on the market -- SportVis, RenehaVis, TRUD, and GAF -- will also be exhibited. SportVis & RenehaVis are injection treatments for treating knee or ankle osteoarthritis; TRUD is a rectal perfusion fluid product for ulcerative colitis and GAF is a wound healing gel for anal fissure.
Should you be interested, please visit us at booth #7808, West Building of Moscone Center.
We look forward to seeing you.